Onconetix, Inc. 8-K

What Happened
On April 24, 2026, Onconetix, Inc. (ONCO) filed an 8‑K reporting that directors Andrew Oakley and Thomas Meier resigned from the Board effective April 20, 2026. Oakley also stepped down as Chairman and from the Audit, Compensation and Nominating & Corporate Governance Committees; Meier resigned from the Compensation Committee. The Board appointed existing director Sammy Dorf as Chairman effective April 23, 2026, and on the same date elected Josh Epstein to the Board as a Class II director (term expiring at the Company’s 2026 annual meeting).

Key Details

• Resignations: Andrew Oakley and Thomas Meier resigned from the Board effective April 20, 2026; neither departure was due to any disagreement with management or the Board.
• New Chairman compensation: Sammy Dorf will be paid $20,000 per year, payable quarterly, beginning on his April 23, 2026 election date.
• New director: Josh Epstein was elected April 23, 2026; he will join the Audit and Compensation Committees and will chair the Nominating & Corporate Governance Committee. His term runs until the 2026 annual meeting.
• Background & governance: Epstein has 20+ years of executive and legal experience in corporate development, capital markets and M&A across multiple industries; he will receive the same compensation as other non‑employee directors. The filing states there are no related‑party transactions or arrangements concerning his selection.

Why It Matters
Board membership and committee leadership affect corporate oversight and strategic decisions. The appointment of a paid Chairman and a new director with capital‑markets and corporate development experience may influence governance priorities and investor relations. The filing contains no indication of disagreement behind the resignations, and compensation for the Chairman role is modest ($20k/year), but investors should note the change in committee composition—particularly for Audit and Nominating & Corporate Governance—and may want to monitor future filings for any further governance or strategic updates.